Epigenetic Regulation of Monocyte and Macrophage Function

Antioxidants and Redox Signaling

Volumn 25, Issue 14, 2016, Pages 758-774

  Hoeksema, Marten A ^a   De Winther, Menno P J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Epigenetics; macrophages; monocytes; transcription factors

Indexed keywords

TRANSCRIPTION FACTOR;

CELL DIFFERENTIATION; ENHANCER REGION; EPIGENETICS; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; MACROPHAGE FUNCTION; MONOCYTE; PRIORITY JOURNAL; REVIEW; ANIMAL; CYTOLOGY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; MACROPHAGE; MACROPHAGE ACTIVATION;

ANIMALS; CELL DIFFERENTIATION; ENHANCER ELEMENTS, GENETIC; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MONOCYTES;

EID: 84993981968     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2016.6695     Document Type: Review

References (142)

1. Adams D, Altucci L, Antonarakis SE, Ballesteros J, Beck S, Bird A, Bock C, Boehm B, Campo E, Caricasole A, Dahl F, Dermitzakis ET, Enver T, Esteller M, Estivill X, Ferguson-Smith A, Fitzgibbon J, Flicek P, Giehl C, Graf T, Grosveld F, Guigo R, Gut I, Helin K, Jarvius J, Kuppers R, Lehrach H, Lengauer T, Lernmark A, Leslie D, Loeffler M, Macintyre E, Mai A, Martens JH, Minucci S, Ouwehand WH, Pelicci PG, Pendeville H, Porse B, Rakyan V, Reik W, Schrappe M, Schubeler D, Seifert M, Siebert R, Simmons D, Soranzo N, Spicuglia S, Stratton M, Stunnenberg HG, Tanay A, Torrents D, Valencia A, Vellenga E, Vingron M, Walter J, and Willcocks S. BLUEPRINT to decode the epigenetic signature written in blood. Nat Biotechnol 30: 224-226, 2012.
2. Alvarez-Errico D, Vento-Tormo R, Sieweke M, and Ballestar E. Epigenetic control of myeloid cell differentiation, identity and function. Nat Rev Immunol 15: 7-17, 2015.
3. Arrowsmith CH, Bountra C, Fish PV, Lee K, and Schapira M. Epigenetic protein families: a new frontier for drug discovery. Nat Rev Drug Discov 11: 384-400, 2012.
4. Arts RJ, Blok BA, van Crevel R, Joosten LA, Aaby P, Benn CS, and Netea MG. Vitamin A induces inhibitory histone methylation modifications and down-regulates trained immunity in human monocytes. J Leukoc Biol 98: 129-136, 2015.
5. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S, Sarnacki S, Cumano A, Lauvau G, and Geissmann F. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317: 666-670, 2007.
6. Austenaa L, Barozzi I, Chronowska A, Termanini A, Ostuni R, Prosperini E, Stewart AF, Testa G, and Natoli G. The histone methyltransferase Wbp7 controls macrophage function through GPI glycolipid anchor synthesis. Immunity 36: 572-585, 2012.
7. Baardman J, Licht I, MP de Winther, Van den Bossche J. Metabolic-epigenetic crosstalk in macrophage activation. Epigenomics 7: 1155-1164, 2015.
8. Bandukwala HS, Gagnon J, Togher S, Greenbaum JA, Lamperti ED, Parr NJ, Molesworth AM, Smithers N, Lee K, Witherington J, Tough DF, Prinjha RK, Peters B, and Rao A. Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors. Proc Natl Acad Sci USA 109: 14532-14537, 2012.
9. Bannister AJ and Kouzarides T. Regulation of chromatin by histone modifications. Cell Res 21: 381-395, 2011.
10. Belkina AC, Nikolajczyk BS, and Denis GV. BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses. J Immunol 190: 3670-3678, 2013.
11. Bellenguez C, Bevan S, Gschwendtner A, Spencer CC, Burgess AI, Pirinen M, Jackson CA, Traylor M, Strange A, Su Z, Band G, Syme PD, Malik R, Pera J, Norrving B, Lemmens R, Freeman C, Schanz R, James T, Poole D, Murphy L, Segal H, Cortellini L, Cheng YC, Woo D, Nalls MA, Muller-Myhsok B, Meisinger C, Seedorf U, Ross-Adams H, Boonen S, Wloch-Kopec D, Valant V, Slark J, Furie K, Delavaran H, Langford C, Deloukas P, Edkins S, Hunt S, Gray E, Dronov S, Peltonen L, Gretarsdottir S, Thorleifsson G, Thorsteinsdottir U, Stefansson K, Boncoraglio GB, Parati EA, Attia J, Holliday E, Levi C, Franzosi MG, Goel A, Helgadottir A, Blackwell JM, Bramon E, Brown MA, Casas JP, Corvin A, Duncanson A, Jankowski J, Mathew CG, Palmer CN, Plomin R, Rautanen A, Sawcer SJ, Trembath RC, Viswanathan AC, Wood NW, Worrall BB, Kittner SJ, Mitchell BD, Kissela B, Meschia JF, Thijs V, Lindgren A, Macleod MJ, Slowik A, Walters M, Rosand J, Sharma P, Farrall M, Sudlow CL, Rothwell PM, Dichgans M, Donnelly P, and Markus HS. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet 44: 328-333, 2012.
12. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL, and Lander ES. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315-326, 2006.
13. Bordon Y. Macrophages: innate memory training. Nat Rev Immunol 14: 713, 2014.
14. Bulger M and Palis J. Environmentally-defined enhancer populations regulate diversity of tissue-resident macrophages. Trends Immunol 36: 61-62, 2015.
15. Cao J and Yan Q. Histone ubiquitination and deubiquitination in transcription, DNA damage response, and cancer. Front Oncol 2: 26, 2012.
16. Cao Q, Rong S, Repa JJ, St Clair R, Parks JS, and Mishra N. Histone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis development. Arterioscler Thromb Vasc Biol 34: 1871-1879, 2014.
17. Cao Q, Wang X, Jia L, Mondal AK, Diallo A, Hawkins GA, Das SK, Parks JS, Yu L, Shi H, Shi H, and Xue B. Inhibiting DNA Methylation by 5-Aza-2'-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation. Endocrinology 155: 4925-4938, 2014.
18. Cecchini MG, Dominguez MG, Mocci S, Wetterwald A, Felix R, Fleisch H, Chisholm O, Hofstetter W, Pollard JW, and Stanley ER. Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development 120: 1357-1372, 1994.
19. Chen X, Barozzi I, Termanini A, Prosperini E, Recchiuti A, Dalli J, Mietton F, Matteoli G, Hiebert S, and Natoli G. Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proc Natl Acad Sci USA 109: E2865-E2874, 2012.
20. Chen X, El Gazzar M, Yoza BK, and McCall CE. The NFkappaB factor RelB and histone H3 lysine methyltransferase G9a directly interact to generate epigenetic silencing in endotoxin tolerance. J Biol Chem 284: 27857-27865, 2009.
21. Cheng SC, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, Giamarellos-Bourboulis EJ, Martens JH, Rao NA, Aghajanirefah A, Manjeri GR, Li Y, Ifrim DC, Arts RJ, van der Veer BM, Deen PM, Logie C, O'Neill LA, Willems P, van de Veerdonk FL, van der Meer JW, Ng A, Joosten LA, Wijmenga C, Stunnenberg HG, Xavier RJ, and Netea MG. mTOR-and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345: 1250684, 2014.
22. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, and Mann M. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325: 834-840, 2009.
23. Christophorou MA, Castelo-Branco G, Halley-Stott RP, Oliveira CS, Loos R, Radzisheuskaya A, Mowen KA, Bertone P, Silva JC, Zernicka-Goetz M, Nielsen ML, Gurdon JB, and Kouzarides T. Citrullination regulates pluripotency and histone H1 binding to chromatin. Nature 507: 104-108, 2014.
24. Dai XM, Ryan GR, Hapel AJ, Dominguez MG, Russell RG, Kapp S, Sylvestre V, and Stanley ER. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99: 111-120, 2002.
25. Davies LC and Taylor PR. Tissue-resident macrophages: then and now. Immunology 144: 541-548, 2015.
26. Dawson MA, Prinjha RK, Dittmann A, Giotopoulos G, Bantscheff M, Chan WI, Robson SC, Chung CW, Hopf C, Savitski MM, Huthmacher C, Gudgin E, Lugo D, Beinke S, Chapman TD, Roberts EJ, Soden PE, Auger KR, Mirguet O, Doehner K, Delwel R, Burnett AK, Jeffrey P, Drewes G, Lee K, Huntly BJ, and Kouzarides T. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 478: 529-533, 2011.
27. De Santa F, Barozzi I, Mietton F, Ghisletti S, Polletti S, Tusi BK, Muller H, Ragoussis J, Wei CL, and Natoli G. A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol 8: e1000384, 2010.
28. De Santa F, Narang V, Yap ZH, Tusi BK, Burgold T, Austenaa L, Bucci G, Caganova M, Notarbartolo S, Casola S, Testa G, Sung WK, Wei CL, and Natoli G. Jmjd3 contributes to the control of gene expression in LPSactivated macrophages. EMBO J 28: 3341-3352, 2009.
29. De Santa F, Totaro MG, Prosperini E, Notarbartolo S, Testa G, and Natoli G. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 130: 1083-1094, 2007.
30. Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E, Gilpatrick T, Paranal RM, Qi J, Chesi M, Schinzel AC, McKeown MR, Heffernan TP, Vakoc CR, Bergsagel PL, Ghobrial IM, Richardson PG, Young RA, Hahn WC, Anderson KC, Kung AL, Bradner JE, and Mitsiades CS. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146: 904-917, 2011.
31. Dinarello CA. Anti-inflammatory Agents: Present and Future. Cell 140: 935-950, 2010.
32. Falkenberg KJ and Johnstone RW. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov 13: 673-691, 2014.
33. Fang TC, Schaefer U, Mecklenbrauker I, Stienen A, Dewell S, Chen MS, Rioja I, Parravicini V, Prinjha RK, Chandwani R, MacDonald MR, Lee K, Rice CM, and Tarakhovsky A. Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response. J Exp Med 209: 661-669, 2012.
34. Farh KK, Marson A, Zhu J, Kleinewietfeld M, Housley WJ, Beik S, Shoresh N, Whitton H, Ryan RJ, Shishkin AA, Hatan M, Carrasco-Alfonso MJ, Mayer D, Luckey CJ, Patsopoulos NA, De Jager PL, Kuchroo VK, Epstein CB, Daly MJ, Hafler DA, and Bernstein BE. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518: 337-343, 2015.
35. This reference has been deleted. 36. Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I, Philpott M, Munro S, McKeown MR, Wang Y, Christie AL, West N, Cameron MJ, Schwartz B, Heightman TD, La Thangue N, French CA, Wiest O, Kung AL, Knapp S, and Bradner JE. Selective inhibition of BET bromodomains. Nature 468: 1067-1073, 2010.
36. Foster SL, Hargreaves DC, and Medzhitov R. Genespecific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972-978, 2007.
37. Galvan-Pena S, O'Neill LA. Metabolic reprograming in macrophage polarization. Front Immunol 5: 420, 2014.
38. Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, and Collins T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci USA 94: 2927-2932, 1997.
39. Ghisletti S, Barozzi I, Mietton F, Polletti S, De Santa F, Venturini E, Gregory L, Lonie L, Chew A, Wei CL, Ragoussis J, and Natoli G. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 32: 317-328, 2010.
40. Ghizzoni M, Haisma HJ, Maarsingh H, and Dekker FJ. Histone acetyltransferases are crucial regulators in NFkappaB mediated inflammation. Drug Discov Today 16: 504-511, 2011.
41. Ginhoux F and Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat Rev Immunol 14: 392-404, 2014.
42. Glass CK and Natoli G. Molecular control of activation and priming in macrophages. Nat Immunol 17: 26-33, 2016.
43. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 3: 23-35, 2003.
44. Gosselin D and Glass CK. Epigenomics of macrophages. Immunol Rev 262: 96-112, 2014.
45. Gosselin D, Link VM, Romanoski CE, Fonseca GJ, Eichenfield DZ, Spann NJ, Stender JD, Chun HB, Garner H, Geissmann F, and Glass CK. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 159: 1327-1340, 2014.
46. Greer EL and Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet 13: 343-357, 2012.
47. Guilliams M, Ginhoux F, Jakubzick C, Naik SH, Onai N, Schraml BU, Segura E, Tussiwand R, and Yona S. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat Rev Immunol 14: 571-578, 2014.
48. Guo C, D'Ippolito AM, and Reddy TE. From prescription to transcription: genome sequence as drug target. Cell 162: 16-17, 2015.
49. Hah N, Benner C, Chong LW, Yu RT, Downes M, and Evans RM. Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs. Proc Natl Acad Sci USA 112: E297-E302, 2015.
50. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, S Van Calcar, Qu C, Ching KA, Wang W, Weng Z, Green RD, Crawford GE, and Ren B. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39: 311-318, 2007.
51. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, and Glass CK. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38: 576-589, 2010.
52. Heinz S, Romanoski CE, Benner C, Allison KA, Kaikkonen MU, Orozco LD, and Glass CK. Effect of natural genetic variation on enhancer selection and function. Nature 503: 487-492, 2013.
53. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, and Manolio TA. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 106: 9362-9367, 2009.
54. Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, Hoke HA, and Young RA. Super-enhancers in the control of cell identity and disease. Cell 155: 934-947, 2013.
55. Hoeffel G and Ginhoux F. Ontogeny of tissue-resident macrophages. Front Immunol 6: 486, 2015.
56. Hoeksema MA, Gijbels MJ, Van den Bossche J, van der Velden S, Sijm A, Neele AE, Seijkens T, Stoger JL, Meiler S, Boshuizen MC, Dallinga-Thie GM, Levels JH, Boon L, Mullican SE, Spann NJ, Cleutjens JP, Glass CK, Lazar MA, de Vries CJ, Biessen EA, Daemen MJ, Lutgens E, and de Winther MP. Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions. EMBO Mol Med 6: 1124-1132, 2014.
57. Hoeksema MA, Scicluna BP, Boshuizen MC, van der Velden S, Neele AE, Van den Bossche J, Matlung HL, van den Berg TK, Goossens P, and de Winther MP. IFNgamma priming of macrophages represses a part of the inflammatory program and attenuates neutrophil recruitment. J Immunol 194: 3909-3916, 2015.
58. Ifrim DC, Quintin J, Joosten LA, Jacobs C, Jansen T, Jacobs L, Gow NA, Williams DL, van der Meer JW, and Netea MG. Trained immunity or tolerance: opposing functional programs induced in human monocytes after engagement of various pattern recognition receptors. Clin Vaccine Immunol 21: 534-545, 2014.
59. Ishii M, Wen H, Corsa CA, Liu T, Coelho AL, Allen RM, Carson WFt, Cavassani KA, Li X, Lukacs NW, Hogaboam CM, Dou Y, and Kunkel SL. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood 114: 3244-3254, 2009.
60. Ivashkiv LB. Epigenetic regulation of macrophage polarization and function. Trends Immunol 34: 216-223, 2013.
61. Jin F, Li Y, Ren B, and Natarajan R. PU. 1 and C/EBP(alpha) synergistically program distinct response to NF-kappaB activation through establishing monocyte specific enhancers. Proc Natl Acad Sci USA 108: 5290-5295, 2011.
62. Kaikkonen MU, Lam MT, and Glass CK. Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc Res 90: 430-440, 2011.
63. Kaikkonen MU, Spann NJ, Heinz S, Romanoski CE, Allison KA, Stender JD, Chun HB, Tough DF, Prinjha RK, Benner C, and Glass CK. Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol Cell 51: 310-325, 2013.
64. Kerenyi MA, Shao Z, Hsu YJ, Guo G, Luc S, K O'Brien, Fujiwara Y, Peng C, Nguyen M, and Orkin SH. Histone demethylase Lsd1 represses hematopoietic stem and progenitor cell signatures during blood cell maturation. Elife 2: e00633, 2013.
65. Kittan NA, Allen RM, Dhaliwal A, Cavassani KA, Schaller M, Gallagher KA, Carson WFT, Mukherjee S, Grembecka J, Cierpicki T, Jarai G, Westwick J, Kunkel SL, and Hogaboam CM. Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypes. PLoS One 8: e78045, 2013.
66. Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Ifrim DC, Saeed S, Jacobs C, van Loenhout J, de Jong D, Stunnenberg HG, Xavier RJ, van der Meer JW, van Crevel R, and Netea MG. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci USA 109: 17537-17542, 2012.
67. Klug M, Schmidhofer S, Gebhard C, Andreesen R, and Rehli M. 5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes. Genome Biol 14: R46, 2013.
68. Ko M, Bandukwala HS, An J, Lamperti ED, Thompson EC, Hastie R, Tsangaratou A, Rajewsky K, Koralov SB, and Rao A. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice. Proc Natl Acad Sci USA 108: 14566-14571, 2011.
69. Kraakman MJ, Murphy AJ, Jandeleit-Dahm K, and Kammoun HL. Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function? Front Immunol 5: 470, 2014.
70. Kramer OH, Knauer SK, Greiner G, Jandt E, Reichardt S, Guhrs KH, Stauber RH, Bohmer FD, and Heinzel T. phosphorylation-acetylation switch regulates STAT1 signaling. Genes Dev 23: 223-235, 2009.
71. Kruidenier L, Chung CW, Cheng Z, Liddle J, Che K, Joberty G, Bantscheff M, Bountra C, Bridges A, Diallo H, Eberhard D, Hutchinson S, Jones E, Katso R, Leveridge M, Mander PK, Mosley J, Ramirez-Molina C, Rowland P, Schofield CJ, Sheppard RJ, Smith JE, Swales C, Tanner R, Thomas P, Tumber A, Drewes G, Oppermann U, Patel DJ, Lee K, and Wilson DM. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 488: 404-408, 2012.
72. Lara-Astiaso D, Weiner A, Lorenzo-Vivas E, Zaretsky I, Jaitin DA, David E, Keren-Shaul H, Mildner A, Winter D, Jung S, Friedman N, and Amit I. Immunogenetics. Chromatin state dynamics during blood formation. Science 345: 943-949, 2014.
73. Lavin Y, Winter D, Blecher-Gonen R, David E, Keren-Shaul H, Merad M, Jung S, and Amit I. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 159: 1312-1326, 2014.
74. Leoni F, Fossati G, Lewis EC, Lee JK, Porro G, Pagani P, Modena D, Moras ML, Pozzi P, Reznikov LL, Siegmund B, Fantuzzi G, Dinarello CA, and Mascagni P. The histone deacetylase inhibitor ITF2357 reduces production of proinflammatory cytokines in vitro and systemic inflammation in vivo. Mol Med 11: 1-15, 2005.
75. Leoni F, Zaliani A, Bertolini G, Porro G, Pagani P, Pozzi P, Dona G, Fossati G, Sozzani S, Azam T, Bufler P, Fantuzzi G, Goncharov I, Kim SH, Pomerantz BJ, Reznikov LL, Siegmund B, Dinarello CA, and Mascagni P. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc Natl Acad Sci USA 99: 2995-3000, 2002.
76. Li Y, Reddy MA, Miao F, Shanmugam N, Yee JK, Hawkins D, Ren B, and Natarajan R. Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation. J Biol Chem 283: 26771-26781, 2008.
77. Li Y, Zhao T, Liu B, Halaweish I, Mazitschek R, Duan X, and Alam HB. Inhibition of histone deacetylase 6 improves long-term survival in a lethal septic model. J Trauma Acute Care Surg 78: 378-385, 2015.
78. Liu Y, Zhang Q, Ding Y, Li X, Zhao D, Zhao K, Guo Z, and Cao X. Histone lysine methyltransferase Ezh1 promotes TLR-triggered inflammatory cytokine production by suppressing Tollip. J Immunol 194: 2838-2846, 2015.
79. Luan B, Goodarzi MO, Phillips NG, Guo X, Chen YD, Yao J, Allison M, Rotter JI, Shaw R, and Montminy M. Leptin-mediated increases in catecholamine signaling reduce adipose tissue inflammation via activation of macrophage HDAC4. Cell Metab 19: 1058-1065, 2014.
80. Mele DA, Salmeron A, Ghosh S, Huang HR, Bryant BM, and Lora JM. BET bromodomain inhibition suppresses TH17-mediated pathology. J Exp Med 210: 2181-2190, 2013.
81. Mitchell AJ, Roediger B, and Weninger W. Monocyte homeostasis and the plasticity of inflammatory monocytes. Cell Immunol 291: 22-31, 2014.
82. Mounce BC, Mboko WP, Kanack AJ, and Tarakanova VL. Primary macrophages rely on histone deacetylase 1 and 2 expression to induce type I interferon in response to gammaherpesvirus infection. J Virol 88: 2268-2278, 2014.
83. Mullican SE, Gaddis CA, Alenghat T, Nair MG, Giacomin PR, Everett LJ, Feng D, Steger DJ, Schug J, Artis D, and Lazar MA. Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation. Genes Dev 25: 2480-2488, 2011.
84. Natoli G and Andrau JC. Noncoding transcription at enhancers: general principles and functional models. Annu Rev Genet 46: 1-19, 2012.
85. Natoli G and Monticelli S. Macrophage activation: glancing into diversity. Immunity 40: 175-177, 2014.
86. Neele AE, Van den Bossche J, Hoeksema MA, and de Winther MP. Epigenetic pathways in macrophages emerge as novel targets in atherosclerosis. Eur J Pharmacol 763: 79-89, 2015.
87. Netea MG, Quintin J, and van der Meer JW. Trained immunity: a memory for innate host defense. Cell Host Microbe 9: 355-361, 2011.
88. Nguyen KD, Fentress SJ, Qiu Y, Yun K, Cox JS, and Chawla A. Circadian gene Bmal1 regulates diurnal oscillations of Ly6C(hi) inflammatory monocytes. Science 341: 1483-1488, 2013.
89. Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, Chung CW, Chandwani R, Marazzi I, Wilson P, Coste H, White J, Kirilovsky J, Rice CM, Lora JM, Prinjha RK, Lee K, and Tarakhovsky A. Suppression of inflammation by a synthetic histone mimic. Nature 468: 1119-1123, 2010.
90. O'Brien KL, Walters MI, Sellman J, Quinlisk P, Regnery H, Schwartz B, and Dowell SF. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis 30: 784-789, 2000.
91. Okabe Y and Medzhitov R. Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Cell 157: 832-844, 2014.
92. Osawa T, Tsuchida R, Muramatsu M, Shimamura T, Wang F, Suehiro J, Kanki Y, Wada Y, Yuasa Y, Aburatani H, Miyano S, Minami T, Kodama T, and Shibuya M. Inhibition of histone demethylase JMJD1A improves antiangiogenic therapy and reduces tumor-associated macrophages. Cancer Res 73: 3019-3028, 2013.
93. Ostuni R, Piccolo V, Barozzi I, Polletti S, Termanini A, Bonifacio S, Curina A, Prosperini E, Ghisletti S, and Natoli G. Latent enhancers activated by stimulation in differentiated cells. Cell 152: 157-171, 2013.
94. Paneni F, Costantino S, Battista R, Castello L, Capretti G, Chiandotto S, Scavone G, Villano A, Pitocco D, Lanza G, Volpe M, Luscher TF, and Cosentino F. Adverse epigenetic signatures by histone methyltransferase Set7 contribute to vascular dysfunction in patients with type 2 diabetes mellitus. Circ Cardiovasc Genet 8: 150-158, 2015.
95. Parker SC, Stitzel ML, Taylor DL, Orozco JM, Erdos MR, Akiyama JA, van Bueren KL, Chines PS, Narisu N, Black BL, Visel A, Pennacchio LA, and Collins FS. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc Natl Acad Sci USA 110: 17921-17926, 2013.
96. Patel MC, Debrosse M, Smith M, Dey A, Huynh W, Sarai N, Heightman TD, Tamura T, and Ozato K. BRD4 coordinates recruitment of pause release factor P-TEFb and the pausing complex NELF/DSIF to regulate transcription elongation of interferon-stimulated genes. Mol Cell Biol 33: 2497-2507, 2013.
97. Poralla L, Stroh T, Erben U, Sittig M, Liebig S, Siegmund B, and Glauben R. Histone deacetylase 5 regulates the inflammatory response of macrophages. J Cell Mol Med 19, 2162-2171, 2015.
98. Pott S and Lieb JD. What are super-enhancers? Nat Genet 47: 8-12, 2015.
99. Qiao Y and Ivashkiv LB. Effect and mechanism of BET bromodomain inhibition in macrophage transcriptional programming. Inflamm Cell Signal 1: 10-14800/ics. 600, 2015.
100. Quintin J, Cheng SC, van der Meer JW, and Netea MG. Innate immune memory: toward a better understanding of host defense mechanisms. Curr Opin Immunol 29: 1-7, 2014.
101. Quintin J, Saeed S, Martens JH, Giamarellos-Bourboulis EJ, Ifrim DC, Logie C, Jacobs L, Jansen T, Kullberg BJ, Wijmenga C, Joosten LA, Xavier RJ, van der Meer JW, Stunnenberg HG, and Netea MG. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 12: 223-232, 2012.
102. Rodrigues J, Brayner FA, Alves LC, Dixit R, and Barillas-Mury C. Hemocyte differentiation mediates innate immune memory in Anopheles gambiae mosquitoes. Science 329: 1353-1355, 2010.
103. Romanoski CE, Link VM, Heinz S, and Glass CK. Exploiting genomics and natural genetic variation to decode macrophage enhancers. Trends Immunol 36: 507-518, 2015.
104. Rossetto D, Avvakumov N, and Cote J. Histone phosphorylation: a chromatin modification involved in diverse nuclear events. Epigenetics 7: 1098-1108, 2012.
105. Saeed S, Quintin J, Kerstens HH, Rao NA, Aghajanirefah A, Matarese F, Cheng SC, Ratter J, Berentsen K, van der Ent MA, Sharifi N, Janssen-Megens EM, Ter Huurne M, Mandoli A, van Schaik T, Ng A, Burden F, Downes K, Frontini M, Kumar V, Giamarellos-Bourboulis EJ, Ouwehand WH, van der Meer JW, Joosten LA, Wijmenga C, Martens JH, Xavier RJ, Logie C, Netea MG, and Stunnenberg HG. Epigenetic programming of monocyte-tomacrophage differentiation and trained innate immunity. Science 345: 1251086, 2014.
106. Satoh T, Takeuchi O, Vandenbon A, Yasuda K, Tanaka Y, Kumagai Y, Miyake T, Matsushita K, Okazaki T, Saitoh T, Honma K, Matsuyama T, Yui K, Tsujimura T, Standley DM, Nakanishi K, Nakai K, and Akira S. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol 11: 936-944, 2010.
107. Schliehe C, Flynn EK, Vilagos B, Richson U, Swaminathan S, Bosnjak B, Bauer L, Kandasamy RK, Griesshammer IM, Kosack L, Schmitz F, Litvak V, Sissons J, Lercher A, Bhattacharya A, Khamina K, Trivett AL, Tessarollo L, Mesteri I, Hladik A, Merkler D, Kubicek S, Knapp S, Epstein MM, Symer DE, Aderem A, and Bergthaler A. The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfection. Nat Immunol 16: 67-74, 2015.
108. Schones DE and Zhao K. Genome-wide approaches to studying chromatin modifications. Nat Rev Genet 9: 179-191, 2008.
109. Schubeler D. Function and information content of DNA methylation. Nature 517: 321-326, 2015.
110. Scruggs BS, Gilchrist DA, Nechaev S, Muse GW, Burkholder A, Fargo DC, and Adelman K. Bidirectional Transcription Arises from Two Distinct Hubs of Transcription Factor Binding and Active Chromatin. Mol Cell 58: 1101-1112, 2015.
111. Shakespear MR, Halili MA, Irvine KM, Fairlie DP, and Sweet MJ. Histone deacetylases as regulators of inflammation and immunity. Trends Immunol 32: 335-343, 2011.
112. Shakespear MR, Hohenhaus DM, Kelly GM, Kamal NA, Gupta P, Labzin LI, Schroder K, Garceau V, Barbero S, Iyer A, Hume DA, Reid RC, Irvine KM, Fairlie DP, and Sweet MJ. Histone deacetylase 7 promotes Toll-like receptor 4-dependent proinflammatory gene expression in macrophages. J Biol Chem 288: 25362-25374, 2013.
113. Sheppard KA, Rose DW, Haque ZK, Kurokawa R, E McInerney, Westin S, Thanos D, Rosenfeld MG, Glass CK, and Collins T. Transcriptional activation by NFkappaB requires multiple coactivators. Mol Cell Biol 19: 6367-6378, 1999.
114. Shi L, Zhang Z, Song L, Leung YT, Petri MA, and Sullivan KE. Monocyte enhancers are highly altered in systemic lupus erythematosus. Epigenomics 7: 921-935, 2015.
115. Sica A and Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122: 787-795, 2012.
116. Soccio RE, Chen ER, Rajapurkar SR, Safabakhsh P, Marinis JM, Dispirito JR, Emmett MJ, Briggs ER, Fang B, Everett LJ, Lim HW, Won KJ, Steger DJ, Wu Y, Civelek M, Voight BF, and Lazar MA. Genetic variation determines PPARgamma function and anti-diabetic drug response in vivo. Cell 162: 33-44, 2015.
117. Squadrito ML, Etzrodt M, De Palma M, and Pittet MJ. MicroRNA-mediated control of macrophages and its implications for cancer. Trends Immunol 34: 350-359, 2013.
118. Stein M, Keshav S, Harris N, and Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176: 287-292, 1992.
119. Stender JD, Pascual G, Liu W, Kaikkonen MU, Do K, Spann NJ, Boutros M, Perrimon N, Rosenfeld MG, and Glass CK. Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20. Mol Cell 48: 28-38, 2012.
120. Tausendschon M, Dehne N, and Brune B. Hypoxia causes epigenetic gene regulation in macrophages by attenuating Jumonji histone demethylase activity. Cytokine 53: 256-262, 2011.
121. Van den Bossche J, Neele AE, Hoeksema MA, de Heij F, Boshuizen MC, van der Velden S, de Boer VC, Reedquist KA, and de Winther MP. Inhibiting epigenetic enzymes to improve atherogenic macrophage functions. Biochem Biophys Res Commun 455: 396-402, 2014.
122. Van den Bossche J, Neele AE, Hoeksema MA, and de Winther MP. Macrophage polarization: the epigenetic point of view. Curr Opin Lipidol 25: 367-373, 2014.
123. Wang J, Mahmud SA, Bitterman PB, Huo Y, and Slungaard A. Histone deacetylase inhibitors suppress TFkappaB-dependent agonist-driven tissue factor expression in endothelial cells and monocytes. J Biol Chem 282: 28408-28418, 2007.
124. West MA and Koons A. Endotoxin tolerance in sepsis: concentration-dependent augmentation or inhibition of LPS-stimulated macrophage TNF secretion by LPS pretreatment. J Trauma 65: 893-898; discussion 898-900, 2008.
125. Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, Rahl PB, Lee TI, and Young RA. Master transcription factors and mediator establish superenhancers at key cell identity genes. Cell 153: 307-319, 2013.
126. Wiktor-Jedrzejczak W and Gordon S. Cytokine regulation of the macrophage (M phi) system studied using the colony stimulating factor-1-deficient op/op mouse. Physiol Rev 76: 927-947, 1996.
127. Williams DJ, Hall M, Brogan TV, Farris RW, Myers AL, Newland JG, and Shah SS. Influenza coinfection and outcomes in children with complicated pneumonia. Arch Pediatr Adolesc Med 165: 506-512, 2011.
128. Xia M, Liu J, Wu X, Liu S, Li G, Han C, Song L, Li Z, Wang Q, Wang J, Xu T, and Cao X. Histone methyltransferase Ash1l suppresses interleukin-6 production and inflammatory autoimmune diseases by inducing the ubiquitin-editing enzyme A20. Immunity 39: 470-481, 2013.
129. Xu G, Liu G, Xiong S, Liu H, Chen X, and Zheng B. The histone methyltransferase Smyd2 is a negative regulator of macrophage activation by suppressing interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) production. J Biol Chem 290: 5414-5423, 2015.
130. Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, De Nardo D, Gohel TD, Emde M, Schmidleithner L, Ganesan H, Nino-Castro A, Mallmann MR, Labzin L, Theis H, Kraut M, Beyer M, Latz E, Freeman TC, Ulas T, and Schultze JL. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40: 274-288, 2014.
131. Yan B, Xie S, Liu Z, Ran J, Li Y, Wang J, Yang Y, Zhou J, Li D, and Liu M. HDAC6 deacetylase activity is critical for lipopolysaccharide-induced activation of macrophages. PLoS One 9: e110718, 2014.
132. Yan Q, Sun L, Zhu Z, Wang L, Li S, and Ye RD. Jmjd3-mediated epigenetic regulation of inflammatory cytokine gene expression in serum amyloid A-stimulated macrophages. Cell Signal 26: 1783-1791, 2014.
133. Yang Q, Wei J, Zhong L, Shi M, Zhou P, Zuo S, Wu K, Zhu M, Huang X, Yu Y, Zhang H, Yin H, and Zhou J. Cross talk between histone deacetylase 4 and STAT6 in the transcriptional regulation of arginase 1 during mouse dendritic cell differentiation. Mol Cell Biol 35: 63-75, 2015.
134. Yang X, Wang X, Liu D, Yu L, Xue B, and Shi H. Epigenetic regulation of macrophage polarization by DNA methyltransferase 3b. Mol Endocrinol 28: 565-574, 2014.
135. Yang Z, Yik JH, Chen R, He N, Jang MK, Ozato K, and Zhou Q. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol Cell 19: 535-545, 2005.
136. Yona S, Kim KW, Wolf Y, Mildner A, Varol D, Breker M, Strauss-Ayali D, Viukov S, Guilliams M, Misharin A, Hume DA, Perlman H, Malissen B, Zelzer E, and Jung S. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38: 79-91, 2013.
137. Yoshida K, Maekawa T, Zhu Y, Renard-Guillet C, Chatton B, Inoue K, Uchiyama T, Ishibashi K-i, Yamada T, and Ohno N. The transcription factor ATF7 mediates lipopolysaccharide-induced epigenetic changes in macrophages involved in innate immunological memory. Nat Immunol 16: 1034-1043, 2015.
138. Zampetaki A, Zeng L, Margariti A, Xiao Q, Li H, Zhang Z, Pepe AE, Wang G, Habi O, deFalco E, Cockerill G, Mason JC, Hu Y, and Xu Q. Histone deacetylase 3 is critical in endothelial survival and atherosclerosis development in response to disturbed flow. Circulation 121: 132-142, 2010.
139. Zhang Q, Zhao K, Shen Q, Han Y, Gu Y, Li X, Zhao D, Liu Y, Wang C, Zhang X, Su X, Liu J, Ge W, Levine RL, Li N, and Cao X. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature 525: 389-393, 2015.
140. Ziegler-Heitbrock L. Blood Monocytes and Their Subsets: Established Features and Open Questions. Front Immunol 6: 423, 2015.
141. Ziegler-Heitbrock L and Hofer TP. Toward a refined definition of monocyte subsets. Front Immunol 4: 23, 2013.
142. Zuber J, Shi J, Wang E, Rappaport AR, Herrmann H, Sison EA, Magoon D, Qi J, Blatt K, Wunderlich M, Taylor MJ, Johns C, Chicas A, Mulloy JC, Kogan SC, Brown P, Valent P, Bradner JE, Lowe SW, and Vakoc CR. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 478: 524-528, 2011.